Dr. Francis Farraye, M.D

NPI: 1427035286
Total Payments
$504,399
2024 Payments
$73,102
Companies
27
Transactions
369
Medicare Patients
1,143
Medicare Billing
$131,258

Payment Breakdown by Category

Consulting$404,097 (80.1%)
Other$55,480 (11.0%)
Travel$24,098 (4.8%)
Education$9,259 (1.8%)
Food & Beverage$5,828 (1.2%)
Research$5,638 (1.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $404,097 132 80.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $30,770 9 6.1%
Honoraria $24,710 6 4.9%
Travel and Lodging $24,098 89 4.8%
Education $9,259 8 1.8%
Food and Beverage $5,828 123 1.2%
Unspecified $5,638 2 1.1%

Payments by Type

General
$498,762
367 transactions
Research
$5,638
2 transactions

Top Paying Companies

Company Total Records Latest Year
Braintree Laboratories, Inc. $90,000 22 $0 (2024)
Janssen Biotech, Inc. $61,350 66 $0 (2024)
PFIZER INC. $55,619 39 $0 (2024)
Eli Lilly and Company $42,800 17 $0 (2024)
ABBVIE INC. $30,972 23 $0 (2024)
Merck Sharp & Dohme Corporation $30,684 26 $0 (2018)
GlaxoSmithKline, LLC. $26,409 15 $0 (2022)
Janssen Scientific Affairs, LLC $24,883 40 $0 (2024)
E.R. Squibb & Sons, L.L.C. $18,625 6 $0 (2023)
Ferring Pharmaceuticals Inc. $18,216 23 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $73,102 62 Janssen Biotech, Inc. ($17,222)
2023 $73,154 64 Janssen Scientific Affairs, LLC ($11,598)
2022 $44,085 30 E.R. Squibb & Sons, L.L.C. ($7,360)
2021 $64,898 22 AbbVie Inc. ($27,884)
2020 $62,432 28 Braintree Laboratories, Inc. ($15,000)
2019 $51,511 38 Braintree Laboratories, Inc. ($17,500)
2018 $74,094 66 Merck Sharp & Dohme Corporation ($20,499)
2017 $61,123 59 Braintree Laboratories, Inc. ($20,000)

All Payment Transactions

369 individual payment records from CMS Open Payments — Page 1 of 15

Date Company Product Nature Form Amount Type
12/21/2024 Janssen Biotech, Inc. TREMFYA (Drug) Consulting Fee Cash or cash equivalent $2,125.00 General
Category: Immunology
12/07/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $38.42 General
Category: Immunology
08/20/2024 PFIZER INC. Consulting Fee Cash or cash equivalent $175.00 General
08/07/2024 Eli Lilly and Company Consulting Fee Cash or cash equivalent $4,800.00 General
06/28/2024 PFIZER INC. VELSIPITY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,500.00 General
Category: INFLAMMATION;PAIN
06/12/2024 PFIZER INC. Consulting Fee Cash or cash equivalent $175.00 General
05/24/2024 Janssen Biotech, Inc. TREMFYA (Drug) Consulting Fee Cash or cash equivalent $2,550.00 General
Category: Immunology
05/22/2024 PFIZER INC. Consulting Fee Cash or cash equivalent $350.00 General
05/17/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $146.28 General
Category: Immunology
05/17/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $19.00 General
Category: Immunology
04/25/2024 PFIZER INC. Consulting Fee Cash or cash equivalent $525.00 General
04/15/2024 Hexal AG Consulting Fee Cash or cash equivalent $3,510.00 General
04/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC Consulting Fee Cash or cash equivalent $9,375.00 General
04/10/2024 Janssen Scientific Affairs, LLC STELARA (Biological) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: Immunology
04/05/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $124.87 General
Category: IMMUNOLOGY
03/21/2024 PFIZER INC. Consulting Fee Cash or cash equivalent $700.00 General
03/19/2024 Janssen Biotech, Inc. TREMFYA (Drug) Travel and Lodging Cash or cash equivalent $60.00 General
Category: Immunology
03/19/2024 Janssen Biotech, Inc. TREMFYA (Drug) Travel and Lodging Cash or cash equivalent $23.80 General
Category: Immunology
03/15/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC Food and Beverage In-kind items and services $42.49 General
03/15/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC Food and Beverage In-kind items and services $29.75 General
03/15/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC Food and Beverage In-kind items and services $21.16 General
03/15/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC Food and Beverage In-kind items and services $12.74 General
03/14/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC Travel and Lodging In-kind items and services $514.20 General
03/14/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC Travel and Lodging In-kind items and services $292.67 General
03/14/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC Travel and Lodging In-kind items and services $96.59 General

Research Studies & Clinical Trials

Study Name Company Amount Records
TOFACITINIB CLINICAL PUBLICATION PROGRAM PFIZER INC. $3,200 1
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate to Severe Crohn's Disease E.R. Squibb & Sons, L.L.C. $2,438 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 280 324 $281,551 $35,463
2022 7 237 262 $248,259 $30,245
2021 9 273 282 $62,859 $30,256
2020 9 353 373 $80,669 $35,294
Total Patients
1,143
Total Services
1,241
Medicare Billing
$131,258
Procedure Codes
31

All Medicare Procedures & Services

31 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 104 145 $65,250 $13,007 19.9%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 72 74 $127,736 $10,219 8.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 35 35 $24,745 $4,008 16.2%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 39 39 $40,504 $3,337 8.2%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 16 16 $14,256 $2,746 19.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 14 15 $9,060 $2,145 23.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 86 107 $48,150 $10,056 20.9%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 58 59 $105,728 $7,299 6.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 21 21 $18,711 $3,700 19.8%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 13 14 $28,266 $2,920 10.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 18 18 $12,726 $2,336 18.4%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 28 30 $26,826 $2,208 8.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 13 13 $7,852 $1,726 22.0%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 77 78 $25,966 $9,798 37.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 49 57 $8,034 $5,188 64.6%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 32 32 $7,152 $5,152 72.0%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 26 26 $5,140 $3,515 68.4%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 16 16 $7,163 $2,952 41.2%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 24 24 $5,307 $1,809 34.1%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 15 15 $2,536 $1,488 58.7%
99211 Established patient outpatient visit, minimal presenting problem Office 2021 12 12 $266.16 $261.72 98.3%
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito Facility 2021 22 22 $1,295 $92.80 7.2%
45380 Biopsy of large bowel using an endoscope Facility 2020 71 71 $28,361 $9,351 33.0%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 59 59 $12,417 $8,908 71.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 51 67 $9,256 $5,108 55.2%

About Dr. Francis Farraye, M.D

Dr. Francis Farraye, M.D is a Internal Medicine healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427035286.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francis Farraye, M.D has received a total of $504,399 in payments from pharmaceutical and medical device companies, with $73,102 received in 2024. These payments were reported across 369 transactions from 27 companies. The most common payment nature is "Consulting Fee" ($404,097).

As a Medicare-enrolled provider, Farraye has provided services to 1,143 Medicare beneficiaries, totaling 1,241 services with total Medicare billing of $131,258. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Gastroenterology, Gastroenterology
  • Location Jacksonville, FL
  • Active Since 12/22/2005
  • Last Updated 08/31/2020
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1427035286

Products in Payments

  • SUPREP BOWEL PREP (Drug) $55,000
  • STELARA (Biological) $53,611
  • SUPREP (Drug) $35,000
  • XELJANZ (Drug) $34,600
  • TREMFYA (Drug) $19,772
  • MONOFERRIC (Drug) $17,110
  • SIMPONI (Biological) $15,074
  • Entyvio (Biological) $14,911
  • ZEPOSIA (Drug) $9,410
  • SHINGRIX (Biological) $8,748
  • PREPOPIK (Drug) $8,088
  • CLENPIQ (Drug) $6,420
  • INFLECTRA (Biological) $5,679
  • REMICADE (Biological) $5,665
  • VELSIPITY (Drug) $4,500
  • Sotyktu (Drug) $1,681
  • Mytesi (Drug) $1,580
  • HUMIRA (Biological) $650.00
  • IDACIO (Biological) $610.00
  • Humira (Biological) $177.20

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Jacksonville